Avanos Medical (AVNS) Research & Development (2013 - 2026)

Avanos Medical has disclosed Research & Development across 14 years of filings, most recently posting $5.2 million for Q1 2026.

• Research & Development for Q1 2026 came in at $5.2 million, down 3.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $23.1 million (down 6.1% YoY), and the FY2025 annual result was $23.3 million, down 11.07% from the prior year.
• Research & Development came in at $5.2 million for Q1 2026 at Avanos Medical, down from $6.1 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $7.8 million in Q1 2022 to a low of $5.2 million in Q1 2026.
• The 5-year median for Research & Development is $6.8 million (2023), against an average of $6.6 million.
• Across the five-year window, Research & Development gained 22.03% in 2022 and slipped 22.86% in 2025, its largest moves.
• Avanos Medical's Research & Development stood at $7.2 million in 2022, then decreased by 5.56% to $6.8 million in 2023, then dropped by 16.18% to $5.7 million in 2024, then grew by 7.02% to $6.1 million in 2025, then retreated by 14.75% to $5.2 million in 2026.
• The last three Research & Development figures came in at $5.2 million (Q1 2026), $6.1 million (Q4 2025), and $6.0 million (Q3 2025), per Business Quant data.